J-F Colombel - JoVE Visualize

Showing results (241-250 of 253) with videos related to

Pageof 26

Sort By:

Alimentary Pharmacology & Therapeutics|January 3, 2013

Development and validation of a patient-reported disability measurement tool for patients with inflammatory bowel diseaseP B Allen, M A Kamm, L Peyrin-Biroulet, et al.

United European Gastroenterology Journal|February 14, 2018

The gut microbiota, bile acids and their correlation in primary sclerosing cholangitis associated with inflammatory bowel diseaseJ Torres, C Palmela, H Brito, et al.

Alimentary Pharmacology & Therapeutics|July 2, 2014

Factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel diseaseM Seirafi, B de Vroey, A Amiot, et al.

The American Journal of Gastroenterology|March 10, 2011

Successive treatment with cyclosporine and infliximab in steroid-refractory ulcerative colitisS Leblanc, M Allez, P Seksik, et al.

Gut|December 27, 2005

Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trialP Marteau, M Lémann, P Seksik, et al.

British Journal of Pharmacology|December 1, 1998

Genotypic and phenotypic analysis of the polymorphic thiopurine S-methyltransferase gene (TPMT) in a European populationC Spire-Vayron de la Moureyre, H Debuysere, B Mastain, et al.

Nature|February 29, 1996

Mapping of a susceptibility locus for Crohn's disease on chromosome 16J P Hugot, P Laurent-Puig, C Gower-Rousseau, et al.

Nature|June 1, 2001

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's diseaseJ P Hugot, M Chamaillard, H Zouali, et al.

International Journal of Colorectal Disease|April 25, 2001

Use of anti-tumour necrosis factor agents in inflammatory bowel disease. European guidelines for 2001-2003S Schreiber, M Campieri, J F Colombel, et al.

Gastroenterology|April 28, 2000

Selective expansion of intraepithelial lymphocytes expressing the HLA-E-specific natural killer receptor CD94 in celiac diseaseB Jabri, N P de Serre, C Cellier, et al.

Pageof 26

Showing results (241-250 of 253) with videos related to

Sort By:

Pageof 26

Alimentary Pharmacology & Therapeutics|January 3, 2013

Development and validation of a patient-reported disability measurement tool for patients with inflammatory bowel diseaseP B Allen, M A Kamm, L Peyrin-Biroulet, et al.

United European Gastroenterology Journal|February 14, 2018

The gut microbiota, bile acids and their correlation in primary sclerosing cholangitis associated with inflammatory bowel diseaseJ Torres, C Palmela, H Brito, et al.

Alimentary Pharmacology & Therapeutics|July 2, 2014

Factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel diseaseM Seirafi, B de Vroey, A Amiot, et al.

The American Journal of Gastroenterology|March 10, 2011

Successive treatment with cyclosporine and infliximab in steroid-refractory ulcerative colitisS Leblanc, M Allez, P Seksik, et al.

Gut|December 27, 2005

Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trialP Marteau, M Lémann, P Seksik, et al.

British Journal of Pharmacology|December 1, 1998

Genotypic and phenotypic analysis of the polymorphic thiopurine S-methyltransferase gene (TPMT) in a European populationC Spire-Vayron de la Moureyre, H Debuysere, B Mastain, et al.

Nature|February 29, 1996

Mapping of a susceptibility locus for Crohn's disease on chromosome 16J P Hugot, P Laurent-Puig, C Gower-Rousseau, et al.

Nature|June 1, 2001

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's diseaseJ P Hugot, M Chamaillard, H Zouali, et al.

International Journal of Colorectal Disease|April 25, 2001

Use of anti-tumour necrosis factor agents in inflammatory bowel disease. European guidelines for 2001-2003S Schreiber, M Campieri, J F Colombel, et al.

Gastroenterology|April 28, 2000

Selective expansion of intraepithelial lymphocytes expressing the HLA-E-specific natural killer receptor CD94 in celiac diseaseB Jabri, N P de Serre, C Cellier, et al.

Pageof 26